首页> 外国专利> PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOTIC DISORDERS

PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOTIC DISORDERS

机译:哌嗪取代的芳基苯二氮杂AND及其作为多巴胺受体拮抗剂治疗精神分裂症的用途

摘要

Described herein are antipyschotic compounds of formula (I) wherein, A is an optionally benzo-fused five or six member aromatic ring having zero to three hetero atoms independently selected from N, O, and S; Alk is (CSUB1-4/SUB) alkylene optionally substituted with OH, methoxy, ethoxy, or F; Ar is optionally substituted phenyl, naphthyl, monocyclic heteroaromatic, or bicyclic heteroaromatic; RSUP1 /SUPis hydrogen or (CSUB1-4/SUB) alkyl optionally substituted with OH, ORSUP3/SUP, or OCHSUB2/SUBCHSUB2/SUBOH, wherein RSUP3 /SUPis (CSUB1-2/SUB) alkyl; RSUP2 /SUPis H, (CSUB1-6/SUB) alkyl, halogen, fluorinated (CSUB1-6/SUB) alkyl, ORSUP4/SUP, SRSUP4/SUP, NOSUB2/SUB, CN, CORSUP4/SUP, CONRSUP5/SUPRSUP6/SUP, SOSUB2/SUBNRSUP5/SUPRSUP6/SUP, NRSUP5/SUPRSUP6/SUP, NRSUP5/SUPCORSUP4/SUP, NRSUP5/SUPSOSUB2/SUBRSUP4/SUP, or optionally substituted phenyl, wherein RSUP4 /SUPis hydrogen, (CSUB1-6/SUB) alkyl, fluorinated (CSUB1-6/SUB) alkyl, or optionally substituted phenyl, RSUP5 /SUPand RSUP6 /SUPare independently hydrogen, (CSUB1-6/SUB) alkyl, or optionally substituted phenyl; Z is one or two substituents independently selected from hydrogen, halogen, (CSUB1-6/SUB) alkyl, fluorinated (CSUB1-6/SUB) alkyl, ORSUP7/SUP, SRSUP7/SUP, NOSUB2/SUB, CN, CORSUP7/SUP, CONRSUP8/SUPRSUP9/SUP, SOSUB2/SUBNRSUP8/SUPRSUP9/SUP, NRSUP8/SUPSOSUB2/SUBRSUP7/SUP, NRSUP8/SUPRSUP9/SUP, or optionally substituted phenyl, wherein RSUP7 /SUPis hydrogen, (CSUB1-6/SUB) alkyl, fluorinated alkyl, or optionally substituted phenyl, RSUP8 /SUPand RSUP9 /SUPare independently hydrogen, (CSUB1-6/SUB) alkyl, or optionally substituted phenyl; and salts, solvates, and crystal forms thereof. Also described are the use of the compounds of formula (I) as antagonists of the dopamine DSUB2 /SUBreceptor and as agents for the treatment of psychosis and bipolar disorder, and pharmaceutical formulations of the compounds of formula (I).
机译:本文所述的式(I)的抗精神分裂化合物,其中,A是任选地苯并稠合的具有零至三个独立地选自N,O和S的杂原子的五或六元芳族环;烷基是任选被OH,甲氧基,乙氧基或F取代的(C 1-4 )亚烷基; Ar为任选取代的苯基,萘基,单环杂芳族或双环杂芳族; R 1 是氢或任选被OH,OR 3 或OCH 2 1-4 )烷基> CH 2 OH,其中R 3 是(C 1-2 )烷基; R 2 是H,(C 1-6 )烷基,卤素,氟化(C 1-6 )烷基,OR 4 ,SR 4 ,NO 2 ,CN,COR 4 ,CONR 5 R 6 ,SO 2 NR 5 R 6 ,NR 5 R 6 ,NR 5 COR 4 ,NR 5 SO 2 R 4 ,或任选取代的苯基,其中R 4 是氢,(C 1-6 )烷基,氟化的(C 1-6 )烷基或任选取代的苯基,R 5 和R 6 独立地为氢,(C 1-6 )烷基或任选取代的苯基; Z是一个或两个独立选自氢,卤素,(C 1-6 )烷基,氟化的(C 1-6 )烷基,OR 7 < / SUP>,SR 7 ,NO 2 ,CN,COR 7 ,CONR 8 R 9 ,SO 2 NR 8 R 9 ,NR 8 SO 2 R 7 ,NR 8 R 9 或可选取代的苯基,其中R 7 是氢,(C 1-6 )烷基,氟化烷基或可选取代的苯基R 8 和R 9 独立地为氢,(C 1 -6 )烷基或可取代的苯基;及其盐,溶剂化物及其晶形。还描述了式(I)的化合物作为多巴胺D 2 受体的拮抗剂和作为用于治疗精神病和双相情感障碍的药物的用途,以及式(I)的化合物的药物制剂)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号